STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a loss of $22 million in its fourth quarter.
On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 81 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.
For the year, the company reported that its loss widened to $57.3 million, or $2.10 per share. Revenue was reported as $86,000.
Cara shares have increased 88 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $17.49, more than tripling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA
Keywords: Cara Therapeutics, Earnings Report